| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020603960 |
| P356 | DOI | 10.1038/NRGASTRO.2016.138 |
| P698 | PubMed publication ID | 27625189 |
| P2093 | author name string | Jean-Pierre Allain | |
| Ohene Opare-Sem | |||
| P2860 | cites work | Infectivity of blood products from donors with occult hepatitis B virus infection | Q42277057 |
| Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa. | Q42280111 | ||
| Isolated core antibody hepatitis B in sub-Saharan African immigrants. | Q42980246 | ||
| One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations | Q42987099 | ||
| Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital | Q42987696 | ||
| Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa | Q43036160 | ||
| Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death | Q43180169 | ||
| Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants | Q43504458 | ||
| Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy | Q43629454 | ||
| Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice | Q43714409 | ||
| Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening? | Q43728391 | ||
| Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization | Q43759169 | ||
| Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers | Q43954106 | ||
| Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. | Q44021728 | ||
| Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa | Q44120640 | ||
| Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay | Q44164538 | ||
| The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana | Q45014102 | ||
| Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase | Q45183486 | ||
| Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B. | Q45217971 | ||
| Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. | Q45350818 | ||
| Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. | Q45362712 | ||
| Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area | Q45363795 | ||
| Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers | Q45365133 | ||
| Occult hepatitis B virus infection in Thai blood donors | Q45369715 | ||
| Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection | Q45369762 | ||
| Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion | Q45372999 | ||
| Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. | Q45373575 | ||
| Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa | Q45383530 | ||
| Strategies for managing coinfection with hepatitis B virus and HIV. | Q45384260 | ||
| Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus | Q45384368 | ||
| Characterization of occult hepatitis B virus strains in South African blood donors | Q45384596 | ||
| Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers | Q26778611 | ||
| Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine | Q28542694 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China | Q30383724 | ||
| Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. | Q30391932 | ||
| Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B | Q30406744 | ||
| Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program | Q33288333 | ||
| Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates | Q33307062 | ||
| Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection | Q33449162 | ||
| Prevalence of hepatitis B virus seromarkers in young adults vaccinated at birth; impact on the epidemiology of hepatitis B infection in iran | Q33580024 | ||
| Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso | Q33693646 | ||
| Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes | Q33815041 | ||
| Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting. | Q33931586 | ||
| The clinical implications of hepatitis B virus genotype: Recent advances. | Q34157245 | ||
| Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria | Q34210772 | ||
| Hepatitis B e antigen-negative chronic hepatitis B. | Q34389603 | ||
| Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan | Q34487699 | ||
| Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. | Q34569561 | ||
| The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective | Q34625481 | ||
| Dried blood spot sampling for hepatitis B virus serology and molecular testing | Q34684010 | ||
| Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay | Q34741067 | ||
| Risk factors associated with hepatitis B exposure and the reliability of five rapid kits commonly used for screening blood donors in Ghana | Q34969698 | ||
| The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011 | Q34994357 | ||
| The economics of treating chronic hepatitis B in Asia | Q34996644 | ||
| High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon | Q35050618 | ||
| Characterization of occult hepatitis B virus infection from blood donors in China | Q35066642 | ||
| Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. | Q35193195 | ||
| Management of hepatitis B in developing countries | Q35635637 | ||
| Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks | Q35684175 | ||
| HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study | Q35688813 | ||
| Hepatitis B virus genotypes and genome characteristics in China | Q35692333 | ||
| Seroepidemiology of hepatitis B virus infection and impact of vaccination | Q35819579 | ||
| Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. | Q35840984 | ||
| HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article | Q36022260 | ||
| Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China | Q36187319 | ||
| Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential? | Q36250930 | ||
| Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study | Q36280421 | ||
| Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four Chinese regional blood centers between 2000 and 2010. | Q36384047 | ||
| Occult HBV infection | Q36518847 | ||
| Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study | Q36767379 | ||
| Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. | Q36821936 | ||
| Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes | Q36855058 | ||
| Hepatitis B viral load in dried blood spots: A validation study in Zambia | Q37122883 | ||
| The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa | Q37156348 | ||
| Diagnostic algorithm for HBV safe transfusion | Q37284917 | ||
| Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy | Q37305696 | ||
| Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. | Q37333836 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| Diagnosis of hepatitis B virus infection through serological and virological markers. | Q37345962 | ||
| The size of the viral inoculum contributes to the outcome of hepatitis B virus infection | Q37356013 | ||
| Statements from the Taormina expert meeting on occult hepatitis B virus infection | Q45391959 | ||
| Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C. | Q45399141 | ||
| Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa | Q45400073 | ||
| Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase | Q45410934 | ||
| Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection | Q45418428 | ||
| Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening | Q45723533 | ||
| Occult HBV infection among a cohort of Nigerian adults. | Q46346147 | ||
| Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. | Q46450252 | ||
| Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings | Q46828957 | ||
| Screening for viral markers in volunteer and replacement blood donors in West Africa | Q46953804 | ||
| Rapid point-of-care first-line screening tests for hepatitis B infection: a meta-analysis of diagnostic accuracy (1980-2010). | Q47700618 | ||
| Nucleic acid testing to detect HBV infection in blood donors. | Q50548264 | ||
| APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. | Q51531964 | ||
| Pathogenesis of hepatitis B virus infection. | Q52928127 | ||
| Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. | Q54327844 | ||
| Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. | Q54498258 | ||
| Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep–COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications | Q56790297 | ||
| Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY) | Q56833902 | ||
| Epidemiology of Hepatocellular Carcinoma | Q58296509 | ||
| Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection | Q73416685 | ||
| Occult hepatitis B virus infection | Q76380039 | ||
| HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up | Q80229621 | ||
| Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus | Q82578790 | ||
| Hepatitis B virus infection | Q83352950 | ||
| INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers | Q84739077 | ||
| Natural history of chronic hepatitis B virus infection and long-term outcome under treatment | Q37389943 | ||
| Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis | Q37404895 | ||
| Is response to antiviral treatment influenced by hepatitis B virus genotype? | Q37688367 | ||
| Antiviral therapy for chronic hepatitis B. | Q37773583 | ||
| Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus | Q37885453 | ||
| Is there any value to hepatitis B virus genotype analysis? | Q37959290 | ||
| Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis | Q38371565 | ||
| Hepatitis B surface antigenaemia and alpha-foetoprotein detection from dried blood spots: applications to field-based studies and to clinical care in hepatitis B virus endemic areas. | Q38455573 | ||
| HBV: Do I treat my immunotolerant patients? | Q38685592 | ||
| Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda | Q38872311 | ||
| Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. | Q38876720 | ||
| Evaluation of commercialized rapid diagnostic testing for some Hepatitis B biomarkers in an area of intermediate endemicity. | Q38987527 | ||
| Seroprevalence of chronic hepatitis B, as determined from dried blood spots, among children and their mothers in central Lao People's Democratic Republic: a multistage, stratified cluster sampling survey | Q39009158 | ||
| Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans | Q39130292 | ||
| Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma. | Q39139520 | ||
| Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen. | Q39197302 | ||
| Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt. | Q39423767 | ||
| Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia | Q39457688 | ||
| Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia | Q39811848 | ||
| Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire | Q39821683 | ||
| Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR. | Q39901614 | ||
| The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China | Q40662201 | ||
| Colorimetric detection of hepatitis B virus (HBV) DNA based on DNA-templated copper nanoclusters | Q40802540 | ||
| Epidemiological characteristics of the carriers with coexistence of HBsAg and anti-HBs based on a community cohort study | Q40873134 | ||
| The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study | Q40910775 | ||
| The human immune response to hepatitis B surface antigen | Q40930736 | ||
| Lessons learned from integrating simultaneous triple point-of-care screening for syphilis, hepatitis B, and HIV in prenatal services through rural outreach teams in Guatemala | Q40945706 | ||
| Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India | Q41005104 | ||
| Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping. | Q41042006 | ||
| Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study | Q41055645 | ||
| Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors | Q41107028 | ||
| The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. | Q41355357 | ||
| Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar | Q41443852 | ||
| Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection | Q41633359 | ||
| Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan | Q41634165 | ||
| High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply | Q41680549 | ||
| Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme | Q41734031 | ||
| Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan | Q42172640 | ||
| Prevalence of "anti-HBc alone" among Syrian blood donors | Q42200432 | ||
| Genetic characterization and genotyping of hepatitis B virus (HBV) isolates from donors with an occult HBV infection | Q42205189 | ||
| Occult hepatitis B infection | Q42209337 | ||
| No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B. | Q42212522 | ||
| A one-step dipstick assay for the on-site detection of nucleic acid | Q42242916 | ||
| Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations | Q42248035 | ||
| Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study | Q42262369 | ||
| Rapid high-throughput genotyping of HBV DNA using a modified hybridization-extension technique | Q42267222 | ||
| Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya | Q42274180 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 643-653 | |
| P577 | publication date | 2016-09-14 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | Screening and diagnosis of HBV in low-income and middle-income countries | |
| P478 | volume | 13 |
| Q53699968 | A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. |
| Q40379062 | Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults |
| Q92205907 | Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort Study |
| Q104283790 | Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso |
| Q37727852 | Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application |
| Q64227009 | Countdown to 2030: eliminating hepatitis B disease, China |
| Q56980636 | Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone |
| Q92762671 | Hepatitis B virus-specific effector CD8+ T cells are an important determinant of disease prognosis: A meta-analysis |
| Q33753902 | Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks |
| Q92293058 | Mass migration to Europe: an opportunity for elimination of hepatitis B virus? |
| Q59354010 | Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran |
| Q92044591 | Occult hepatitis B infection among blood donors from Yaoundé, Cameroon |
| Q60912102 | Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah |
| Q92495937 | The hepatitis B core antibody positive/hepatitis B surface antigen negative pattern is associated with the increased risk of intracranial atherosclerotic stenosis |
| Q92580393 | Towards better diagnostic tools for liver injury in low-income and middle-income countries |
Search more.